PRICE T ROWE ASSOCIATES INC /MD/ - EDGEWISE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of EDGEWISE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$722
-25.4%
125,704
+0.8%
0.00%
Q2 2023$968
+18.2%
124,680
+1.7%
0.00%
Q1 2023$819
-64.5%
122,570
-52.6%
0.00%
Q4 2022$2,309
-99.9%
258,326
+0.8%
0.00%
Q3 2022$2,522,000
-9.3%
256,238
-26.6%
0.00%
Q2 2022$2,780,000
-18.1%
349,223
-0.2%
0.00%
Q1 2022$3,393,000349,7750.00%
Other shareholders
EDGEWISE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,553,661$8,902,47811.43%
Novo Holdings A/S 6,071,703$34,790,8582.57%
Orbimed Advisors 14,567,176$83,469,9181.77%
Opaleye Management Inc. 875,405$5,016,0711.63%
Cormorant Asset Management, LP 2,946,887$16,885,6630.98%
DAFNA Capital Management LLC 519,384$2,976,0700.93%
EcoR1 Capital, LLC 3,493,194$20,016,0020.68%
Deep Track Capital, LP 2,750,000$15,757,5000.61%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,933,137$22,536,8750.50%
Parkman Healthcare Partners LLC 473,312$2,712,0780.50%
View complete list of EDGEWISE THERAPEUTICS INC shareholders